Correlation Between Sk Biopharmaceutica and Elentec

Can any of the company-specific risk be diversified away by investing in both Sk Biopharmaceutica and Elentec at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sk Biopharmaceutica and Elentec into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sk Biopharmaceuticals Co and Elentec Co, you can compare the effects of market volatilities on Sk Biopharmaceutica and Elentec and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sk Biopharmaceutica with a short position of Elentec. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sk Biopharmaceutica and Elentec.

Diversification Opportunities for Sk Biopharmaceutica and Elentec

0.78

Correlation Coefficient

Sk Biopharmaceutica  Elentec

Poor diversification

The 3 months correlation between 326030 and Elentec is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Sk Biopharmaceuticals Co and Elentec Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elentec and Sk Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sk Biopharmaceuticals Co are associated (or correlated) with Elentec. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elentec has no effect on the direction of Sk Biopharmaceutica i.e., Sk Biopharmaceutica and Elentec go up and down completely randomly.

Pair Corralation between Sk Biopharmaceutica and Elentec

Assuming the 90 days trading horizon Sk Biopharmaceuticals Co is expected to generate 0.9 times more return on investment than Elentec. However, Sk Biopharmaceuticals Co is 1.11 times less risky than Elentec. It trades about 0.05 of its potential returns per unit of risk. Elentec Co is currently generating about -0.06 per unit of risk. If you would invest  7,160,000  in Sk Biopharmaceuticals Co on October 23, 2024 and sell it today you would earn a total of  3,710,000  from holding Sk Biopharmaceuticals Co or generate 51.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	99.79%
Values	Daily Returns

Sk Biopharmaceuticals Co  vs.  Elentec Co

Sk Biopharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sk Biopharmaceuticals Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Elentec

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Elentec Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Sk Biopharmaceutica and Elentec

The main advantage of trading using opposite Sk Biopharmaceutica and Elentec positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sk Biopharmaceutica position performs unexpectedly, Elentec can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elentec will offset losses from the drop in Elentec's long position.

The idea behind Sk Biopharmaceuticals Co and Elentec Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.